Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huisheng Ganlu Wan is a traditional Tibetan medicine manufactured by **Xizang Ganlu Tibetan Medicine**. It is an approved pharmaceutical product in China (National Drug License Number Z20023196). The formulation is primarily indicated for respiratory conditions, specifically those categorized as 'lung diseases' in Tibetan medicine, such as pulmonary tuberculosis, chronic bronchitis, and asthma. Its therapeutic actions include nourishing Yin, moistening the lungs, resolving phlegm, and relieving cough. It is typically administered orally as a pill.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huisheng Ganlu Wan.